Hoatlin Lab

From OpenWetWare
(Redirected from Hoatlin)
Jump to navigationJump to search

Equipped with his five senses, man explores the universe around him and calls the adventure Science. ~Edwin Powell Hubble, The Nature of Science, 1954

Home        Projects        Team        Papers        Contact Us        Protocols        Collaborations        News        Reagent Requests        secret back door        Hoatlin Lab Twitter       



Lab News

For news, follow the Hoatlin lab Twitter


Our laboratory is interested in understanding the molecular function of the Fanconi anemia (FA) protein network in context with other proteins that regulate or influence genomic stability. Fanconi anemia is a rare genetic disease that is typically associated with developmental abnormalities, bone marrow failure and increased risk of cancer. Because the majority of the FA proteins are unique with no significant homologies, we expect the results of our studies to shed new light on fundamental mechanisms that control the integrity of the human genome and influence cancer susceptibility. The FA pathway is part of a network of proteins that contains BRCA2 and two other recently identified FA genes (FANCN and FANCJ) that influence breast cancer susceptibility. Ultimately, insights into the mechanism of the FA/BRCA network of proteins will lead to an understanding of the underlying molecular defect in FA and may lead to more effective avenues of treatment for this devastating pediatric disease and cancer.

We work in Portland, Oregon at OHSU, in the Department of Biochemistry & Molecular Biology and the OHSU Knight Cancer Institute.

Bio for Maureen Hoatlin

Maureen Hoatlin is an Associate Professor of Biochemistry & Molecular Biology, and Molecular & Medical Genetics at Oregon Health & Science University (OHSU). After earning a B.S. degree in Chemistry from Old Dominion University, she was a project chemist at SRI International in Menlo Park, CA for two years, followed by six years as a research associate at Genentech, Inc. She received a Ph.D. at Oregon Health & Science University for graduate work focusing on the role of retroviruses in pathogenesis and hematopoietic cancers. She joined the faculty in Hematology & Medical Oncology at OHSU in 1993, and was a Visiting Scientist & Professor in the Department of Genetics at the Free University and Medical Center of Amsterdam in 1998 and in 2002. Dr. Hoatlin’s research is focused on identifying and analyzing the function of the proteins in the Fanconi Anemia/Breast Cancer (FA/BRCA) cancer susceptibility pathway. Her work has contributed to the discovery and characterization of ten novel human genes, many with critical but poorly understood roles in hematopoiesis, cancer susceptibility (AML and other cancers), and resistance to certain commonly-used chemotherapeutic drugs. Dr. Hoatlin’s lab pioneered a cell-free approach to analyze the function of the FA/BRCA pathway and recently received a patent for a novel small molecule inhibitor screen for identification of FA/BRCA pathway inhibitors and potential chemosensitizing compounds.

Dr. Hoatlin has recently completed an MBA with a specialty on international business in Asia, as well a specialized UCSF course (ACDRS) on the drug development pipeline that focuses on preparation for future developments and changes in the global pharmaceutical sector. Dr. Hoatlin is a member of the strategic planning leadership for OHSU’s School of Medicine, the Hematologic Malignancies Program, advisory board member of the Oregon Translational Research and Development Institute, and founding co-chair of the OHSU Rare Disease Consortium. Dr. Hoatlin is interested in developing industry-academic partnerships aimed at using rare disease research to de-risk drug development.

Teaching Links

  • Our lab's Fanconi Anemia antibodies are available from Novus Biologicals and by Millipore.

PMCB Conjoint Class 2018-2019

Genetic Mechanisms Class (CON662)

Med Students Fundamentals

Biochemistry Seminar Series

Biochemistry Seminar Series and Combined Series Working Draft

Classes of the past

CONJ606/PMCB 2017-2018

Advanced Topics in Molecular Biology(BMB625)

Advanced Topics in Cancer Biology (CANB 610)

OHSU DNA Replication, Recombination and Repair (R3) Club.

Basic Wiki/OWW Links

<wikionly>

Recent changes
List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

28 October 2020

     23:12  BIOL368/F20:Class Journal Week 8‎‎ 7 changes history +12,022 [Taylor Makela‎; Jcorrey‎; BallonaBuddy‎; Nidapatel‎ (2×); Aiden Burnett‎ (2×)]
     
23:12 (cur | prev) +2,559 BallonaBuddy talk contribs group journal entry
     
22:44 (cur | prev) +2,430 Taylor Makela talk contribs Added Taylor Makela Response
     
21:57 (cur | prev) +2,406 Jcorrey talk contribs added my responses - JT
     
21:52 (cur | prev) +778 Aiden Burnett talk contribs →‎Aiden Burnett's response: wrote text
 m   
21:48 (cur | prev) +2 Nidapatel talk contribs →‎Nida Patel Responses: fixing formatting on Nidas response
 m   
21:47 (cur | prev) +2,827 Nidapatel talk contribs Nidas Journal entry
     
21:33 (cur | prev) +1,020 Aiden Burnett talk contribs →‎Aiden Burnett's response: wrote text
     23:02  Template:Taylor Makela diffhist +69 Taylor Makela talk contribs →‎Template Links: added link to class homepage with schedule
     22:59  FoldamerDB Review‎‎ 7 changes history +5,171 [Aiden Burnett‎; Taylor Makela‎ (6×)]
     
22:59 (cur | prev) -8 Taylor Makela talk contribs final formatting changes!
     
22:55 (cur | prev) +408 Taylor Makela talk contribs →‎Acknowledgments: added acknowledgements
     
22:45 (cur | prev) +101 Taylor Makela talk contribs →‎Acknowledgments: added Taylor's signature
     
22:05 (cur | prev) +46 Taylor Makela talk contribs →‎References: adjusted reference formatting
     
22:01 (cur | prev) +703 Taylor Makela talk contribs fixed grammatical/formatting errors and added to references
     
21:35 (cur | prev) +3,584 Taylor Makela talk contribs →‎Database Evaluation: completed the general utility section
     
21:22 (cur | prev) +337 Aiden Burnett talk contribs →‎Scientific Conclusion: wrote text
     22:04  Nathan R Beshai Week 8 diffhist +252 Nathan R. Beshai talk contribs added signiture
     22:02  Claire A. Kosewic Lab Notebook‎‎ 22 changes history +5,134 [Claire A. Kosewic‎ (22×)]
     
22:02 (cur | prev) +2,721 Claire A. Kosewic talk contribs →‎Summary of Work/Ideas To Date
     
21:39 (cur | prev) +36 Claire A. Kosewic talk contribs →‎Fall 2020 Week 9 | October 25, 2020
     
21:38 (cur | prev) +41 Claire A. Kosewic talk contribs →‎Fall 2020 Week 8 | October 18, 2020
     
21:37 (cur | prev) +795 Claire A. Kosewic talk contribs →‎Fall 2020 Week 8 | October 18, 2020
     
21:27 (cur | prev) +1,438 Claire A. Kosewic talk contribs →‎Fall 2020 Week 8 | October
     
21:15 (cur | prev) -440 Claire A. Kosewic talk contribs →‎Fall 2020 Week 8 | October 18, 2020
     
21:15 (cur | prev) -1 Claire A. Kosewic talk contribs →‎Research Meeting Notes October
     
21:14 (cur | prev) +437 Claire A. Kosewic talk contribs →‎Frequency Data from OpenSNP and Personal Genomes Project
     
21:13 (cur | prev) 0 Claire A. Kosewic talk contribs →‎Fall 2020 Week 7 | October 18, 2020
     
21:13 (cur | prev) 0 Claire A. Kosewic talk contribs →‎Fall 2020 Week 6 | October 11, 2020
     
21:12 (cur | prev) 0 Claire A. Kosewic talk contribs →‎Fall 2020 Week 5 | October 4, 2020
     
21:11 (cur | prev) 0 Claire A. Kosewic talk contribs →‎Fall 2020 Week 9 | October
     
21:11 (cur | prev) 0 Claire A. Kosewic talk contribs →‎Fall 2020 Week 8 | October 18, 2020
     
21:10 (cur | prev) 0 Claire A. Kosewic talk contribs →‎Week 6 Research Meeting Notes
     
21:10 (cur | prev) 0 Claire A. Kosewic talk contribs →‎Fall 2020 Week 7 | October 11, 2020
     
21:10 (cur | prev) 0 Claire A. Kosewic talk contribs →‎Fall 2020 Week 6 | October 4, 2020
     
21:09 (cur | prev) -17 Claire A. Kosewic talk contribs →‎Research Meeting Notes from October 21, 2020
     
21:08 (cur | prev) 0 Claire A. Kosewic talk contribs →‎Fall 2020 Week 9 | October 18, 2020
     
21:07 (cur | prev) 0 Claire A. Kosewic talk contribs →‎Fall 2020 | Week 9 October 18, 2020
     
21:06 (cur | prev) -9 Claire A. Kosewic talk contribs →‎Research Meeting Notes from October 15, 2020
     
21:05 (cur | prev) 0 Claire A. Kosewic talk contribs →‎Research Meeting Notes from October 21, 2020
     
21:04 (cur | prev) +133 Claire A. Kosewic talk contribs →‎Research Meeting Notes from October 21, 2020
     21:54  CancerTracer Review‎‎ 7 changes history +3,292 [Nidapatel‎; Jcorrey‎ (6×)]
     
21:54 (cur | prev) -137 Nidapatel talk contribs →‎Summary judgment
     
21:28 (cur | prev) +492 Jcorrey talk contribs →‎References: added class journal readings
     
21:25 (cur | prev) +475 Jcorrey talk contribs →‎Acknowledgements: added more acknowledgements
     
21:23 (cur | prev) +50 Jcorrey talk contribs added template
     
21:22 (cur | prev) +398 Jcorrey talk contribs →‎References: added references
     
21:17 (cur | prev) +1,909 Jcorrey talk contribs →‎Scientific quality of the database: added answers
     
21:14 (cur | prev) +105 Jcorrey talk contribs →‎General information about the database: fixed hyperlinks
     21:43  Therapeutic Target Database (TTD) Review‎‎ 5 changes history +2,089 [Macie Duran‎; BallonaBuddy‎ (4×)]
     
21:43 (cur | prev) +180 Macie Duran talk contribs →‎References: added references to shared journal articles
     
21:24 (cur | prev) 0 BallonaBuddy talk contribs typo
     
21:23 (cur | prev) +363 BallonaBuddy talk contribs acknowledging the work we both did
     
21:19 (cur | prev) +218 BallonaBuddy talk contribs scientific conclusion
     
21:06 (cur | prev) +1,328 BallonaBuddy talk contribs summary judgment

</wikionly>